Altanib Nova 400mg Tablet

About

Altanib Nova 400mg Tablet is an oral targeted therapy belonging to the class of tyrosine kinase inhibitors (TKIs). It works by selectively inhibiting specific protein kinases that are crucial for the growth and proliferation of cancer cells. By blocking these signaling pathways, Altanib Nova effectively halts tumor progression and induces apoptosis in susceptible cancer cells, offering a more targeted approach compared to traditional chemotherapy.

This medication is particularly effective in cancers driven by specific genetic mutations or overexpression of certain receptor tyrosine kinases. Its oral formulation provides convenience for patients, allowing for outpatient administration. Regular monitoring for efficacy and adverse events is essential throughout the treatment course to optimize patient outcomes.

Uses

• Treatment of chronic myeloid leukemia (CML).
• Management of gastrointestinal stromal tumors (GIST).
• Therapy for renal cell carcinoma.
• Treatment of certain types of thyroid cancer.

Directions For Use

Take orally, usually once daily, with or without food as directed by your doctor. Do not crush or chew the tablet.

Benefits

• Targeted therapy with specific anti-cancer action.
• Oral formulation offers convenience for patients.
• Effective in cancers with specific molecular targets.
• Can improve progression-free survival.
• Potentially fewer systemic side effects than conventional chemotherapy.
• Allows for long-term management of chronic cancers.

Side Effects

• Fatigue
• Nausea and vomiting
• Diarrhea or constipation
• Rash
• Fluid retention (edema, especially periorbital)
• Muscle cramps or pain
• Headache
• Abdominal pain
• Changes in liver function tests
• Hypertension (high blood pressure)
• Myelosuppression (low blood counts)
• Hand-foot syndrome

Safety Measures

• Alcohol - Limit alcohol intake as it may increase the risk of liver toxicity or exacerbate gastrointestinal side effects.
• Pregnancy - Contraindicated in pregnancy due to potential for fetal harm. Use effective contraception during treatment and for a period after.
• Breastfeeding - Not recommended during breastfeeding as the drug may be excreted in breast milk and harm the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments are often required, and liver function should be monitored.
• Kidney - Use with caution in patients with renal impairment; dose adjustments may be necessary based on kidney function.
• Lung - Monitor for potential pulmonary adverse events, including interstitial lung disease, though rare.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.